IGF1 and hydrops fetalis: Conduct longitudinal studies to assess the long-term effects of PT alterations on HF progression.Elucidate the role of IGF-1 signalling and other pathways in mediating PT hypertrophy induced by loop diuretic therapy.Conduct clinical trials to identify predictors of optimal response to SGLT2 inhibitors in HF patients.